HEALTHLINE MEDIA UK LIMITED – Trademark Portfolio
Entity Type: 03
HEALTHLINE MEDIA UK LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MNT. The owner is based in SAN FRANCISCO, GA.
660 THIRD STREET
SAN FRANCISCO, GA 30339
Showing of trademarks Trademarks
Trademark Classifications
HEALTHLINE MEDIA UK LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does HEALTHLINE MEDIA UK LIMITED have?
HEALTHLINE MEDIA UK LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does HEALTHLINE MEDIA UK LIMITED file in?
HEALTHLINE MEDIA UK LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are HEALTHLINE MEDIA UK LIMITED's most well-known trademarks?
HEALTHLINE MEDIA UK LIMITED's registered trademark portfolio includes well-known marks such as MNT. These are among 1 currently registered trademark in the portfolio.
What is HEALTHLINE MEDIA UK LIMITED's trademark registration success rate?
HEALTHLINE MEDIA UK LIMITED has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.